Valuation: ImmuneOncia Therapeutics, Inc.

Market Cap 230B 172M 155M 143M 130M 245M 16.15B 251M 1.72B 685M 8.65B 646M 632M 27.52B P/E 2024 *
-
P/E 2025 -33.4x
Enterprise Value 207B 155M 139M 129M 116M 220M 14.51B 226M 1.54B 615M 7.77B 581M 568M 24.73B EV / Sales 2024 *
-
EV / Sales 2025 8,473x
Free-Float
43.51%
Yield 2024 *
-
Yield 2025 -
1 day+1.41%
1 week-0.79%
Current month+0.20%
1 month-23.64%
3 months-26.74%
6 months-57.58%
Current year-80.65%
1 week 2,330
Extreme 2330
2,550
1 month 2,330
Extreme 2330
3,205
Current year 2,300
Extreme 2300
14,240
1 year 2,300
Extreme 2300
16,110
3 years 2,300
Extreme 2300
16,110
5 years 2,300
Extreme 2300
16,110
10 years 2,300
Extreme 2300
16,110
Manager TitleAgeSince
Chief Executive Officer 70 20/07/2021
Director of Finance/CFO 55 25/12/2023
Chief Tech/Sci/R&D Officer 54 -
Director TitleAgeSince
Director/Board Member 70 20/07/2021
Director/Board Member 55 25/12/2023
Director/Board Member 69 29/03/2021
Change 5-day change 1-year change 3-year change Capi.($)
+1.41%-0.79%-52.27% - 172M
-1.06%-0.07%+60.76%+68.61% 67.53B
+1.30%+7.41%+14.79%+92.69% 60.74B
+0.39%+0.30%+20.04%+98.33% 55.66B
-0.95%+11.17%+22.21%+110.93% 47.97B
-0.23%+4.07%+25.63%+40.08% 45.24B
-6.40%-9.51%+181.99%+816.79% 39.08B
+1.97%+3.50%+25.78%+50.98% 35.34B
-0.56%-0.48%+85.57%+65.40% 33.45B
+1.05%+9.77%-37.66%+408.42% 26.49B
Average -0.31%+1.53%+34.68%+194.69% 41B
Weighted average by Cap. -0.48%+1.64%+44.26%+169.14%

Financials

2024 2025
Net sales 655M 489K 441K 407K 368K 697K 45.88M 714K 4.88M 1.95M 24.57M 1.84M 1.8M 78.2M 111M 83.12K 74.92K 69.21K 62.57K 118K 7.8M 121K 829K 331K 4.18M 312K 305K 13.29M
Net income -5.69B -4.25M -3.83M -3.54M -3.2M -6.05M -399M -6.2M -42.42M -16.91M -214M -15.95M -15.61M -679M -27.36B -20.45M -18.43M -17.03M -15.4M -29.13M -1.92B -29.85M -204M -81.35M -1.03B -76.76M -75.12M -3.27B
Net Debt -11.23B -8.39M -7.57M -6.99M -6.32M -11.96M -787M -12.25M -83.77M -33.39M -422M -31.5M -30.83M -1.34B -23.37B -17.47M -15.74M -14.54M -13.15M -24.87M -1.64B -25.49M -174M -69.47M -877M -65.55M -64.16M -2.79B
Projected Income Statement - Annual - ImmuneOncia Therapeutics, Inc.
Logo ImmuneOncia Therapeutics, Inc.
ImmuneOncia Therapeutics Inc is a Korea-based company principally engaged in the research and development of biopharmaceuticals. The Company is principally engaged in the research and development of antibody-based cancer immunotherapy treatments.
Employees
-
Date Price Change Volume
11/11/26 ₩2,520.00 +1.41% 143,685
10/11/26 ₩2,485.00 +4.41% 99,544
09/11/26 ₩2,380.00 0.00% 172,947
06/11/26 ₩2,380.00 -5.56% 253,215
05/11/26 ₩2,520.00 -0.79% 224,016
  1. Stock Market
  2. Stocks
  3. A424870 Stock